Abstract
Several copper complexes have been assessed as anti-tumor agents against cancer cells. In this work, a copper compound [Cu(H2O){OS(CH3)2}L](NO3)2 incorporating the ligand 4′-phenyl-terpyridine antiproliferative activity against human colorectal, hepatocellular carcinomas and breast adenocarcinoma cell lines was determined, demonstrating high cytotoxicity. The compound is able to induce apoptosis and a slight delay in cancer cell cycle progression, probably by its interaction with DNA and induction of double-strand pDNA cleavage, which is enhanced by oxidative mechanisms. Moreover, proteomic studies indicate that the compound induces alterations in proteins involved in cytoskeleton maintenance, cell cycle progression and apoptosis, corroborating its antiproliferative potential.
Similar content being viewed by others
References
Macías B, Villa MV, Gómez B, Borrás J, Alzuet G, González-Álvarez M, Castiñeiras A (2007) J Inorg Biochem 101:444–451
Martins P, Marques M, Coito L, Pombeiro AJ, Baptista PV, Fernandes AR (2014) Anticancer Agents Med Chem 14:1199–1212
Lakovidis I, Delimaris I, Piperakis SM (2011) Mol Biol Int 2011:13
Marzano C, Pellei M, Tisato F, Santini C (2009) Anticancer Agents Med Chem 9:185–211
Balakrishna MS, Suresh D, Rai A, Mague JT, Panda D (2010) Inorg Chem 49:8790–8801
Köpf-Maier P (1994) Eur J Clin Pharmacol 47:1–16
Rajalakshmi S, Weyhermüller T, Freddy AJ, Vasanthi HR, Nair BU (2011) Eur J Med Chem 46:608–617
Rajendiran V, Karthik R, Palaniandavar M, Stoeckli-Evans H, Periasamy VS, Akbarsha MA, Srinag BS, Krishnamurthy H (2007) Inorg Chem 46:8208–8221
Mookerjee A, Basu JM, Majumder S, Chatterjee S, Panda GS, Dutta P, Pal S, Mukherjee P, Efferth T, Roy S, Choudhuri SK (2006) BMC Cancer 6:267
Liu C, Zhou J, Li Q, Wang L, Liao Z, Xu H (1999) J Inorg Biochem 75:233–240
Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Mol Cell Biochem 266:37–56
Kehrer JP (2000) Toxicology 149:43–50
Halliwell B, Gutteridge JM (1990) Methods Enzymol 186:1–85
Theophanides T, Anastassopoulou J (2002) Crit Rev Oncol Hematol 42:57–64
Silva PP, Guerra W, Silveira JN, Ferreira AM, Bortolotto T, Fischer FL, Terenzi H, Neves A, Pereira-Maia EC (2001) Inorg Chem 50:6414–6424
Abdi K, Hadadzadeh H, Weil M, Salimi M (2012) Polyhedron 31:638–648
Rajalakshmi S, Weyhermüller T, Dinesh M, Nair BU (2012) J Inorg Biochem 117:48–59
Ma Z, Wei L, Alegria EC, Martins LM, Guedes da Silva MF, Pombeiro AJ (2014) Dalton Trans 43:4048–4058
Cao P, Cai X, Lu W, Zhou F, Huo J (2011) Evid-Based Compl Alt 2011:9
Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G (2011) Nat Rev Drug Discov 10:221–237
Ho TF, Ma CJ, Lu CH, Tsai YT, Wei YH, Chang JS, Lai JK, Cheuh PJ, Yeh CT, Tang PC, Tsai Chang J, Ko JL, Liu FS, Yen HE, Chang CC (2007) Toxicol Appl Pharmacol 225:318–328
Ghobrial IM, Witzig TE, Adjei AA (2005) CA Cancer J Clin 55:178–194
Wong RS (2011) J Exp Clin Cancer Res 30:87
Elmore S (2007) Toxicol Pathol 35:495–516
Lewin B (2004) Genes, 8th edn. Pearson Prentice Hall, Saddle River, pp 843–937
Li D, Tian J, Kou Y, Huang F, Chen G, Gu W, Liu X, Liao D, Cheng P, Yan S (2009) Dalton Trans 18:3574–3583
Ramakrishnan S, Suresh E, Riyasdeen A, Akbarsha MA, Palaniandavar M (2011) Dalton Trans 40:3245–3256
Luís DV, Silva J, Tomaz AI, de Almeida RFM, Larguinho M, Baptista PV, Martins LMDRS, Silva TFS, Borralho PM, Rodrigues CMP, Rodrigues AS, Pombeiro AJL, Fernandes AR (2014) J Biol Inorg Chem 19:787–803
Rey NA, Neves A, Silva PP, Paula FC, Silveira JN, Botelho FV, Vieira LQ, Pich CT, Terenzi H, Pereira-Maia EC (2009) J Inorg Biochem 103:1323–1330
Hoog PD, Boldron C, Gamez P, Sliedregt-Bol K, Roland I, Pitié M, Kiss R, Meunier B, Reedijk J (2007) J Med Chem 50:3148–3152
Li MJ, Lan TY, Cao XH, Yang HH, Shi Y, Yi C, Chen GN (2014) Dalton Trans 43:2789–2798
Branum ME, Tipton AK, Zhu S, Que L Jr (2001) J Am Chem Soc 123:1898–1904
Liao W, McNutt MA, Zhu WG (2009) Methods 48:46–53
Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R (1997) Mutat Res 375:183–193
Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli L, Kruszewski M, Smith CC, Stetina R (2008) Mutagenesis 23:143–151
Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P (2012) Mol Aspects Med 33:209–290
Naik PN, Chimatadar SA, Nandibewoor ST (2010) J Photoch Photobio B 100:147–159
Kandagal PB, Ashoka S, Seetharamappa J, Shaikh SMT, Jadegoud Y, Ijare OB (2006) J Pharmaceut Biomed 41:393–399
Silva D, Cortez CM, Cunha-Bastos J, Louro SR (2004) Toxicol Lett 147:53–61
Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M (2009) Biochem J 417:651–666
Ostergaard M, Hansen GA, Vorum H, Honoré B (2006) Proteomics 6:3509–3519
Oh SJ, Ryu CK, Choi I, Baek SY, Lee H (2012) Immune Netw 12:66–69
Afshar N, Black BE, Paschal BM (2005) Mol Cell Biol 25:8844–8853
Zhang B, Zhang Y, Dagher MC, Shacter E (2005) Cancer Res 65:6054–6062
Ciocca DR, Arrigo AP, Calderwood SK (2013) Arch Toxicol 87:19–48
Sarto C, Binz PA, Mocarelli P (2000) Electrophoresis 21:1218–1226
Boudiaf-Benmammar C, Cresteil T, Melki R (2013) PLoS One 8:e60895
Pierrard MA, Kestemont P, Phuong NT, Tran MP, Delaive E, Thezenas ML, Dieu M, Raes M, Silvestre F (2012) J Proteomics 75:2454–2467
Brackley KI, Grantham J (2009) Cell Stress Chaperones 14:23–31
Arcuri F, Papa S, Carducci S, Romagnol R, Liberatori S, Riparbelli MG, Sanchez JC, Tosi P, del Vecchio MT (2004) Prostate 60:130–140
Yarm FR (2002) Mol Cell Biol 22:6209–6221
Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer UA (1999) J Cell Sci 112:1257–1271
Pressinotti NC, Klocker H, Schafer G, Luu VD, Ruschhaupt M, Kuner R, Steiner E, Poustka A, Bartsch G, Sultmann H (2009) Mol Cancer 8:130
Gruber CW, Čemažar M, Heras B, Martin JL, Craik DJ (2006) Trends Biochem Sci 31:455–464
Gibert B, Hadchity E, Czekalla A, Aloy MT, Colas P, Rodriguez-Lafrasse C, Arrigo AP, Diaz-Latoud C (2011) Oncogene 30:3672–3681
Concannon CG, Gorman AM, Samali A (2003) Apoptosis 8:61–70
McGee AM, Douglas DL, Liang Y, Hyder SM, Baines CP (2011) Cell Cycle 10:4119–4127
McGee AM, Baines CP (2011) Biochem J 433:119–125
Han J, Won EJ, Hwang DS, Rhee JS, Kim IC, Lee JS (2013) Comp Biochem Physiol Part C: Toxicol Pharmacol 158:91–100
Burns C, Geraghty R, Neville C, Murphy A, Kavanagh K, Doyle S (2005) Fungal Genet Biol 42:319–327
Sheehan D, Meade G, Foley V, Dowd C (2001) Biochem J 360:1–16
Niki E (2009) Free Radic Biol Med 47:469–484
Sen A, Joseph VB, Singh KG (2013) J Biotech Pharmac Res 4:42–47
Silva TFS, Smoleński P, Martins LMDRS, Guedes da Silva MFC, Fernandes AR, Luis D, Silva A, Santos S, Borralho PM, Rodrigues CMP, Pombeiro AJL (2013) Eur J Inorg Chem 2013:3651–3658
Silva TF, Martins LM, Guedes da Silva MF, Fernandes AR, Silva A, Borralho PM, Santos S, Rodrigues CM, Pombeiro AJ (2012) Dalton Trans 41:12888–12897
Silva A, Luis D, Santos S, Silva J, Mendo AS, Coito L, Silva TF, da Silva MF, Martins LM, Pombeiro AJ, Borralho PM, Rodrigues CM, Cabral MG, Videira PA, Monteiro C, Fernandes AR (2013) Drug Metabol Drug Interact 28:167–176
Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM (2009) FEBS J 276:6689–6700
Aslanoglu M (2006) Anal Sci 22:439–443
Shahabadi N, Mohammadi S, Alizadeh R (2011) Bioinorg Chem Appl 2011:1–8
Równicka-Zubik J, Sułkowska A, Dubas M, Pożycka J, Maciążek-Jurczyk M, Bojko B, Sułkowski WW (2011) J Mol Struct 993:477–484
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases—first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
Uchiyama M, Mihara M (1978) Anal Biochem 86:271–278
Li Y, Liu J, Li Q (2010) Mol Carcinog 49:566–581
Livak KJ, Schmittgen TD (2001) Methods 25:402–408
Cui X, Witalison EE, Chumanevich AP, Chumanevich AA, Poudyal D, Subramanian V, Schetter AJ, Harris CC, Thompson PR, Hofseth LJ (2013) PLoS One 8:e53791
Zhang P, Zhang Z, Zhou X, Qiu W, Chen F, Chen W (2006) BMC Cancer 6:1–11
Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN (2009) P Natl Acad Sci 106:12968–12973
Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL (2010) Genes Chromosom Cancer 49:518–525
Coqueret O (2003) Trends Cell Biol 13:65–70
Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K (2000) Oncogene 19:1346–1353
Sandal T (2002) Oncologist 7:73–81
Malumbres M, Barbacid M (2009) Nat Rev Cancer 9:153–166
Garrett MD (2001) Curr Sci 81:515–522
Martinez EJ, Corey EJ, Owa T (2001) Chem Biol 8:1151–1160
Manikandamathavan VM, Rajapandian V, Freddy AJ, Weyhermüller T, Subramanian V, Nair BU (2012) Eur J Med Chem 57:449–458
Zhou W, Wang X, Hu M, Guo Z (2013) J Inorg Biochem 121:114–120
Liang JW, Wang Y, Du KJ, Li GY, Guan RL, Ji LN, Chao H (2014) J Inorg Biochem 141:17–27
Acknowledgments
We thank FCT/MEC for financial support (PTDC/BBB-NAN/1812/2012; PEst-OE/QUI/UI0100/2013). We also thank A. Silva, J. Palma, L. Coito and J. Silva for technical support; and G. Cabral (CEDOC, FCM/UNL) for technical support with flow cytometry assays.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mendo, A.S., Figueiredo, S., Roma-Rodrigues, C. et al. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine. J Biol Inorg Chem 20, 935–948 (2015). https://doi.org/10.1007/s00775-015-1277-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-015-1277-z